首页 > 最新文献

Gastroenterology Hepatology and Digestive System最新文献

英文 中文
Treatment of Barrett's esophagus with low-grade dysplasia using Hibrid-APC 混合apc治疗Barrett食管低度发育不良
Pub Date : 2022-09-01 DOI: 10.33425/2833-4418.0001
Mildred Cecilia Armenteros Torres, R. Quintanilla, Elizabeth Montes de Oca Megias, Vivianne ne Anido Escobar, N. Contino
Introduction: Barrett's esophagus (BE) with low-grade dysplasia represents a risk of progression towards esophageal adenocarcinoma. Hybrid-APC turns out to be an effective, safe, easy to use and relatively low-cost technique to stop this progression. Aims: to describe the therapeutic response of Hybrid-APC in patients with low-grade dysplasia in Barrett's esophagus. Method: an observational, descriptive investigation of a series of cases was carried out at the National Center for Minimal Access Surgery between December 2018 and December 2020. Twenty patients with BE histologically classified with low-grade dysplasia were included. Ablation with Hybrid APC was applied, and endoscopy was performed three and six months after the end of the treatment. The therapeutic response was evaluated through histological remission and the presence of complications. The information was processed in the statistical program SPSS, version 21. Results: mean age 50.5 (range 27-81 years). 55% (11) are male. Eighty-five percent were asymptomatic and 90% had circumferential BE. 55% (11) required a HybridAPC session. With an average of 1.4 sessions, macroscopic and histological remission without dysplasia was achieved at three and six months in 90% (18/20) and 92.8% (13/14) of the patients respectively, without witnessing complications. Conclusions: endoscopic treatment with the Hybrid-APC has a good therapeutic response, with a good histological remission and without complications, in patients with low-grade dysplasia in BE.
巴雷特食管(BE)伴低级别发育不良有发展为食管腺癌的风险。事实证明,混合apc是一种有效、安全、易于使用且相对低成本的技术,可以阻止这种进展。目的:描述Hybrid-APC治疗Barrett食管低度发育不良患者的疗效。方法:对2018年12月至2020年12月在国家微创手术中心进行的一系列病例进行观察性描述性调查。包括20例组织学分类为低级别不典型增生的BE患者。应用混合APC消融,治疗结束后3个月和6个月进行内窥镜检查。通过组织学缓解和并发症的出现来评估治疗反应。在SPSS统计程序中处理这些信息,版本21。结果:平均年龄50.5岁(范围27 ~ 81岁)。55%(11)是男性。85%无症状,90%有周向性BE。55%(11)需要一个HybridAPC会话。平均1.4个疗程,90%(18/20)和92.8%(13/14)的患者分别在3个月和6个月达到宏观和组织学缓解,无不典型增生,无并发症。结论:Hybrid-APC内镜治疗BE低度发育不良患者具有良好的治疗效果,组织学缓解良好,无并发症。
{"title":"Treatment of Barrett's esophagus with low-grade dysplasia using Hibrid-APC","authors":"Mildred Cecilia Armenteros Torres, R. Quintanilla, Elizabeth Montes de Oca Megias, Vivianne ne Anido Escobar, N. Contino","doi":"10.33425/2833-4418.0001","DOIUrl":"https://doi.org/10.33425/2833-4418.0001","url":null,"abstract":"Introduction: Barrett's esophagus (BE) with low-grade dysplasia represents a risk of progression towards esophageal adenocarcinoma. Hybrid-APC turns out to be an effective, safe, easy to use and relatively low-cost technique to stop this progression. Aims: to describe the therapeutic response of Hybrid-APC in patients with low-grade dysplasia in Barrett's esophagus. Method: an observational, descriptive investigation of a series of cases was carried out at the National Center for Minimal Access Surgery between December 2018 and December 2020. Twenty patients with BE histologically classified with low-grade dysplasia were included. Ablation with Hybrid APC was applied, and endoscopy was performed three and six months after the end of the treatment. The therapeutic response was evaluated through histological remission and the presence of complications. The information was processed in the statistical program SPSS, version 21. Results: mean age 50.5 (range 27-81 years). 55% (11) are male. Eighty-five percent were asymptomatic and 90% had circumferential BE. 55% (11) required a HybridAPC session. With an average of 1.4 sessions, macroscopic and histological remission without dysplasia was achieved at three and six months in 90% (18/20) and 92.8% (13/14) of the patients respectively, without witnessing complications. Conclusions: endoscopic treatment with the Hybrid-APC has a good therapeutic response, with a good histological remission and without complications, in patients with low-grade dysplasia in BE.","PeriodicalId":130129,"journal":{"name":"Gastroenterology Hepatology and Digestive System","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122362098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current issues in hepatitis E: an overview 戊型肝炎的当前问题:综述
Pub Date : 2022-09-01 DOI: 10.33425/2833-4418.0003
P. Mohammad K.
{"title":"Current issues in hepatitis E: an overview","authors":"P. Mohammad K.","doi":"10.33425/2833-4418.0003","DOIUrl":"https://doi.org/10.33425/2833-4418.0003","url":null,"abstract":"","PeriodicalId":130129,"journal":{"name":"Gastroenterology Hepatology and Digestive System","volume":"58 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129532359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Patency of spleno-pancreatorenal shunt in infant with portal hypertension, case series and literature review 门静脉高压症患儿脾胰肾分流通畅、病例分析及文献复习
Pub Date : 2022-09-01 DOI: 10.33425/2833-4418.0002
P. J. Aurelus, Rafael Roberto Zapata Carrión, Sandra Karina Diaz Cardona, Sofía Brenes Guzmán, María Del Sol Granados Alonso, Ramón Eduardo Salgado Sangri, Hermilo De La Cruz Yáñez
Introduction: Portal hypertension is the main cause of morbidity and mortality in infant diagnosed of biliary atresia (BA) and cavernous deformation of the portal vein. Portal hypertension evolves as a result of increased intrahepatic vascular resistance, most commonly caused by a chronic liver disease. The clinical manifestations are ascites and bleeding owing the esophageal and gastric varices. The mortality rate per acute episode of bleeding is 5% to 19% in children. The aim of this work was to evaluate the clinical influence of rebleeding, refractory ascites, child-Pugh class (C.P) and shunt patency in infant underwent spleno-pancreatorenal (SPR) shunt in a case series in a pediatric reference medical center. Patients and Methods: Retrospective and observational work was performed owing clinical surveillance of C.P, shunt patency, rebleeding and ascites formation after SPR shunt procedure from December 2017 to November 2020. Of 16 shunts performed in this period, 3(18.7%) patients had SPR shunt. The three patients were females and the mean weight was 6.5kg. Outcomes and Results: The search identified three patients underwent surgical shunts of SPR less than 2-year-old. All of three patients had shunt patency in the first three months from the procedure. One patient had thrombosis of the shunt at fourth month from the operation. The three patients had improvement in the C.P class, 1 patient had infectious, rebleeding and ascites between 4 months from the procedure. Conclusion: The three patients had no experienced shunt complications in the first three months from the procedure.
导语:门静脉高压是诊断为胆道闭锁(BA)和门静脉海绵样变形的婴儿发病和死亡的主要原因。门静脉高压是肝内血管阻力增加的结果,最常见的是由慢性肝病引起的。临床表现为食道及胃底静脉曲张引起的腹水及出血。在儿童中,每次急性出血的死亡率为5%至19%。本研究的目的是在儿科参考医疗中心的一个病例系列中评估再出血、难治性腹水、child-Pugh级(C.P)和分流管通畅对接受脾胰肾(SPR)分流术的婴儿的临床影响。患者和方法:对2017年12月至2020年11月SPR分流术后cp、分流管通畅、再出血和腹水形成的临床监测进行回顾性观察。在此期间进行的16例分流术中,3例(18.7%)患者有SPR分流术。3例患者均为女性,平均体重6.5kg。结果和结果:本研究确定了3例2岁以下SPR手术分流的患者。所有三名患者在手术后的前三个月都有分流通畅。1例患者术后第4个月发生分流管血栓形成。3例患者的cp等级有所改善,1例患者在术后4个月内出现感染、再出血和腹水。结论:3例患者术后3个月内均未发生分流术并发症。
{"title":"Patency of spleno-pancreatorenal shunt in infant with portal hypertension, case series and literature review","authors":"P. J. Aurelus, Rafael Roberto Zapata Carrión, Sandra Karina Diaz Cardona, Sofía Brenes Guzmán, María Del Sol Granados Alonso, Ramón Eduardo Salgado Sangri, Hermilo De La Cruz Yáñez","doi":"10.33425/2833-4418.0002","DOIUrl":"https://doi.org/10.33425/2833-4418.0002","url":null,"abstract":"Introduction: Portal hypertension is the main cause of morbidity and mortality in infant diagnosed of biliary atresia (BA) and cavernous deformation of the portal vein. Portal hypertension evolves as a result of increased intrahepatic vascular resistance, most commonly caused by a chronic liver disease. The clinical manifestations are ascites and bleeding owing the esophageal and gastric varices. The mortality rate per acute episode of bleeding is 5% to 19% in children. The aim of this work was to evaluate the clinical influence of rebleeding, refractory ascites, child-Pugh class (C.P) and shunt patency in infant underwent spleno-pancreatorenal (SPR) shunt in a case series in a pediatric reference medical center. Patients and Methods: Retrospective and observational work was performed owing clinical surveillance of C.P, shunt patency, rebleeding and ascites formation after SPR shunt procedure from December 2017 to November 2020. Of 16 shunts performed in this period, 3(18.7%) patients had SPR shunt. The three patients were females and the mean weight was 6.5kg. Outcomes and Results: The search identified three patients underwent surgical shunts of SPR less than 2-year-old. All of three patients had shunt patency in the first three months from the procedure. One patient had thrombosis of the shunt at fourth month from the operation. The three patients had improvement in the C.P class, 1 patient had infectious, rebleeding and ascites between 4 months from the procedure. Conclusion: The three patients had no experienced shunt complications in the first three months from the procedure.","PeriodicalId":130129,"journal":{"name":"Gastroenterology Hepatology and Digestive System","volume":"75 Suppl 1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"130805150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complicated Crohn’s disease: An unusual destination of an enterocutaneous fistula 复杂的克罗恩病:一个不寻常的目的地肠皮瘘
Pub Date : 2022-09-01 DOI: 10.33425/2833-4418.0004
Emran Alali, R. Bosio, T. Alhmoud
{"title":"Complicated Crohn’s disease: An unusual destination of an enterocutaneous fistula","authors":"Emran Alali, R. Bosio, T. Alhmoud","doi":"10.33425/2833-4418.0004","DOIUrl":"https://doi.org/10.33425/2833-4418.0004","url":null,"abstract":"","PeriodicalId":130129,"journal":{"name":"Gastroenterology Hepatology and Digestive System","volume":"43 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123569248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Esophageal Neuroendocrine Tumor: Case Report 食管神经内分泌肿瘤1例
Pub Date : 2022-09-01 DOI: 10.33425/2833-4418.0005
Letícia Mocellin, Eduarda Paitl Agostinho, Vinicius beck da Silveira, M. Gonçalves, João Alfredo Diedrich Neto
Introduction: Neuroendocrine tumors, also called neuroendocrine carcinomas, are those that form in any region of the neuroendocrine system. Although they are more common in the gastrointestinal tract (67.5%), their appearance in the esophagus is rare. Another important characteristic is its slow growth and low degree of aggressiveness. Case report: A46-year-old male patient, seeking care for progressive phagia for solidspathstenoses digestive endoscopy that showed the diagnosis of distal esophagus whose anatomoological and immunohistochemical was of a neuroendocrine esophageal tumor. Subjected to staging, there were numerous liver metastases and lymph node enlargement of the celiac trunk, and palliative treatment was chosen. The patient had an unfavorable evolution, progressing to jaundice, ascites, worsening of general condition, progressed to death in about 3 months after diagnosis. Discussion: The incidence and prevalence of neuroendocrine esophageal tumor has been increasing since 1970 due to the modernization of diagnostic techniques. Despite the increase in diagnostic capacity, this pathology remains rare, corresponding to 0.15% - 2.80% of esophageal carcinomas. The median survival time for patients with this neoplasm is 22.4 months, having a totally different evolution from other neuroendocrine tumors of the digestive tract..
简介:神经内分泌肿瘤,也称为神经内分泌癌,是在神经内分泌系统的任何区域形成的肿瘤。虽然它们在胃肠道中更常见(67.5%),但在食道中出现却很少见。它的另一个重要特点是生长缓慢,攻击性低。病例报告:一名46岁男性患者,因进行性吞咽合并固体性脊索狭窄求医,消化内镜检查诊断为食管远端,解剖及免疫组化检查为神经内分泌性食管肿瘤。受分期影响,腹腔干有大量肝转移和淋巴结肿大,选择姑息治疗。患者病情发展不利,进展为黄疸、腹水,一般情况恶化,诊断后约3个月死亡。讨论:自1970年以来,由于诊断技术的现代化,神经内分泌食管癌的发病率和患病率一直在增加。尽管诊断能力有所提高,但这种病理仍然很少见,约占食管癌的0.15% - 2.80%。该肿瘤患者的中位生存时间为22.4个月,与其他消化道神经内分泌肿瘤的发展完全不同。
{"title":"Esophageal Neuroendocrine Tumor: Case Report","authors":"Letícia Mocellin, Eduarda Paitl Agostinho, Vinicius beck da Silveira, M. Gonçalves, João Alfredo Diedrich Neto","doi":"10.33425/2833-4418.0005","DOIUrl":"https://doi.org/10.33425/2833-4418.0005","url":null,"abstract":"Introduction: Neuroendocrine tumors, also called neuroendocrine carcinomas, are those that form in any region of the neuroendocrine system. Although they are more common in the gastrointestinal tract (67.5%), their appearance in the esophagus is rare. Another important characteristic is its slow growth and low degree of aggressiveness. Case report: A46-year-old male patient, seeking care for progressive phagia for solidspathstenoses digestive endoscopy that showed the diagnosis of distal esophagus whose anatomoological and immunohistochemical was of a neuroendocrine esophageal tumor. Subjected to staging, there were numerous liver metastases and lymph node enlargement of the celiac trunk, and palliative treatment was chosen. The patient had an unfavorable evolution, progressing to jaundice, ascites, worsening of general condition, progressed to death in about 3 months after diagnosis. Discussion: The incidence and prevalence of neuroendocrine esophageal tumor has been increasing since 1970 due to the modernization of diagnostic techniques. Despite the increase in diagnostic capacity, this pathology remains rare, corresponding to 0.15% - 2.80% of esophageal carcinomas. The median survival time for patients with this neoplasm is 22.4 months, having a totally different evolution from other neuroendocrine tumors of the digestive tract..","PeriodicalId":130129,"journal":{"name":"Gastroenterology Hepatology and Digestive System","volume":"120 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131425503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Gastroenterology Hepatology and Digestive System
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1